Patents by Inventor Thomas Shaw Moody

Thomas Shaw Moody has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11091752
    Abstract: A Squalene Hopene Cyclase (SHC) isolated from Gluconobacter morbifer is provided as are variants and a method for using the G. morbifer SHC to biocatalytically convert homofarnesol to ambroxan.
    Type: Grant
    Filed: February 26, 2018
    Date of Patent: August 17, 2021
    Assignee: INTERNATIONAL FLAVORS & FRAGRANCES INC.
    Inventors: Thomas Shaw Moody, Iain Robert Miskelly, Derek John Quinn
  • Publication number: 20200385700
    Abstract: A Squalene Hopene Cyclase (SHC) isolated from Gluconobacter morbifer is provided as are variants and a method for using the G. morbifer SHC to biocatalytically convert homofarnesol to ambroxan.
    Type: Application
    Filed: February 26, 2018
    Publication date: December 10, 2020
    Inventors: Thomas Shaw Moody, Iain Robert Miskelly, Derek John Quinn
  • Publication number: 20180093943
    Abstract: Disclosed is a process for the preparation of certain intermediates, e.g. those in the scheme below: which intermediates and processes are useful in the preparation of the macrocyclic HVC inhibitor Simeprevir.
    Type: Application
    Filed: March 25, 2016
    Publication date: April 5, 2018
    Applicant: Janssen Pharmaceuticals, Inc.
    Inventors: Dominique Paul Michel Depré, Dominic John Ormerod, Andras Horvath, Thomas Shaw Moody, Maude Brossat, Olivier Riant, Nicolas Vriamont, Sébastien Francois Emmanuel Lemaire, Sébastien Nicolas J. Hermant